Nitisinone (brand name Orfadin) is a medication used to treat a rare genetic condition called hereditary tyrosinemia type 1 (HT-1). It works by blocking an enzyme that breaks down the amino acid tyrosine, which helps to reduce the levels of toxic substances in the body. Nitisinone is usually taken as a capsule once a day, with or without food. Common side effects include nausea, vomiting, abdominal pain, and diarrhea. More serious side effects, such as liver and kidney problems, can occur.
Nitisinone, sold under the brand name Orfadin among others, is a medication used to treat hereditary tyrosinemia type 1 (HT-1).
Here's a summary of Nitisinone:
- Medical Use: Treats hereditary tyrosinemia type 1 (HT-1), a rare genetic disorder that causes the body to be unable to properly break down the amino acid tyrosine.
- Mechanism of Action: Nitisinone works by inhibiting an enzyme called 4-hydroxyphenylpyruvate dioxygenase (HPPD). This enzyme is involved in the early stages of tyrosine breakdown. By inhibiting HPPD, nitisinone reduces the production of harmful byproducts that can accumulate in the body and cause damage to the liver, kidneys, and nervous system in people with HT-1.
- Dosage: Available in capsule and liquid form, the usual dosage is determined by the individual's body weight and response to treatment.
- Side Effects: Nitisinone can cause some side effects, including headache, vomiting, diarrhea, and low blood cell counts.
Important Note: Nitisinone is a prescription medication and should only be taken under the supervision of a qualified healthcare professional. It is not a cure for HT-1, but it can help to manage the condition and improve quality of life for people with this disorder.